CH551010A - Verfahren zur herstellung eines markierten reagin-immunoglobulins. - Google Patents

Verfahren zur herstellung eines markierten reagin-immunoglobulins.

Info

Publication number
CH551010A
CH551010A CH115171A CH115171A CH551010A CH 551010 A CH551010 A CH 551010A CH 115171 A CH115171 A CH 115171A CH 115171 A CH115171 A CH 115171A CH 551010 A CH551010 A CH 551010A
Authority
CH
Switzerland
Prior art keywords
reagin
immunoglobulin
labeled
producing
reagin immunoglobulin
Prior art date
Application number
CH115171A
Other languages
English (en)
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE12297/67A external-priority patent/SE341239B/xx
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of CH551010A publication Critical patent/CH551010A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1015—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1078—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an immunoglobulin, i.e. being an (anti)-anti-idiotypic antibody
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH115171A 1967-09-06 1968-09-02 Verfahren zur herstellung eines markierten reagin-immunoglobulins. CH551010A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE12297/67A SE341239B (de) 1967-09-06 1967-09-06
CH1313868A CH534878A (de) 1967-09-06 1968-09-02 Verfahren zur Bestimmung der Anwesenheit von gegen bestimmte Allergene gerichteten Reagin-Immunoglobulinen (Reagin-Ig) in wässrigen Proben

Publications (1)

Publication Number Publication Date
CH551010A true CH551010A (de) 1974-06-28

Family

ID=25711627

Family Applications (2)

Application Number Title Priority Date Filing Date
CH115171A CH551010A (de) 1967-09-06 1968-09-02 Verfahren zur herstellung eines markierten reagin-immunoglobulins.
CH115071A CH551009A (de) 1967-09-06 1968-09-02 Verfahren zur herstellung markierter antikoerper gegen reagin-immunoglobuline.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH115071A CH551009A (de) 1967-09-06 1968-09-02 Verfahren zur herstellung markierter antikoerper gegen reagin-immunoglobuline.

Country Status (1)

Country Link
CH (2) CH551010A (de)

Also Published As

Publication number Publication date
CH551009A (de) 1974-06-28

Similar Documents

Publication Publication Date Title
CH554848A (de) Verfahren zur herstellung neuer stilben-derivate.
CH554140A (de) Verfahren zur herstellung eines fleischartigen proteinproduktes.
CH517522A (de) Verfahren zur Herstellung eines Katalysators
AT302530B (de) Verfahren zur Herstellung einer Salbenfolie
CH554643A (de) Verfahren zur herstellung eines sauren milchgetraenks.
AT298690B (de) Verfahren zur herstellung neuer halogenpregnadiene
AT279169B (de) Verfahren zur herstellung eines vernetzten polyamidharzes
AT296390B (de) Verfahren zur Herstellung eines Feldeffekttransistors
CH554928A (de) Verfahren zur herstellung eines pigmentes.
CH525263A (de) Verfahren zur Herstellung eines Polyimids
AT301650B (de) Verfahren zur Herstellung eines Hohlleiters
CH530658A (de) Verfahren zur Herstellung eines Transmissionshologramms
CH491605A (de) Verfahren zur Herstellung eines Margarineöls
CH554905A (de) Verfahren zur herstellung eines latex-copolymerisates.
CH553212A (de) Verfahren zur herstellung von neuen tricyclischen enaminen.
AT313542B (de) Verfahren zur Herstellung eines Bauelements
CH500298A (de) Verfahren zur Herstellung eines Monofadens
AT330349B (de) Verfahren zur herstellung eines ubertragungsfaktors
CH522233A (de) Verfahren zur Herstellung eines Hologramms
AT297250B (de) Verfahren zur Herstellung eines Bauelementes
CH558373A (de) Verfahren zur herstellung neuer azacycloaliphatischer verbindungen.
CH515629A (de) Verfahren zur Herstellung eines gabelförmigen Kontaktelementes
AT304066B (de) Verfahren zur Herstellung eines Schichtkörpers
AT281934B (de) Verfahren zur Herstellung eines Leuchtstoffes
AT275980B (de) Verfahren zur Herstellung eines Verbundrohres

Legal Events

Date Code Title Description
PL Patent ceased